These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 6249836)
1. Sensitization of T-lymphocytes in Graves' and Hashimoto's diseases. Okita N; Kidd A; Row VV; Volpé R J Clin Endocrinol Metab; 1980 Aug; 51(2):316-20. PubMed ID: 6249836 [No Abstract] [Full Text] [Related]
2. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor. Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288 [TBL] [Abstract][Full Text] [Related]
3. Patterns of cellular immune responses to thyrocyte membrane antigens and specific immunoregulatory defects in autoimmune thyroid disease. O'Brien CJ; Macchia E; Cundy TF; Concetti R; McSorley CG; MacFarlane IG; Vento S; Eddleston AL J Clin Lab Immunol; 1990 Jul; 32(3):103-8. PubMed ID: 1966945 [TBL] [Abstract][Full Text] [Related]
4. Evidence for thyroid antigen-reactive T lymphocytes infiltrating the thyroid gland in Graves' disease. Tötterman TH; Andersson LC; Häyry P Clin Endocrinol (Oxf); 1979 Jul; 11(1):59-68. PubMed ID: 391444 [TBL] [Abstract][Full Text] [Related]
5. Distribution of T-, B-, and thyroglobulin-binding lymphocytes infiltrating the gland in Graves' disease, Hashimoto's thyroiditis, and de Quervain's thyroiditis. Tötterman TH Clin Immunol Immunopathol; 1978 Jul; 10(3):270-7. PubMed ID: 307474 [No Abstract] [Full Text] [Related]
14. Opposite changes in serum soluble CD8 in patients at the active stages of Graves' and Hashimoto's diseases. Watanabe M; Amino N; Hochito K; Watanabe K; Kuma K; Iwatani Y Thyroid; 1997 Oct; 7(5):743-7. PubMed ID: 9349577 [TBL] [Abstract][Full Text] [Related]
15. Rosette inhibition test for the demonstration of thymus-dependent lymphocyte sensitization in Graves's disease and Hashimoto's thyroiditis. Farid NR; Munro RE; Row VV; Volpé R N Engl J Med; 1973 Nov; 289(21):1111-7. PubMed ID: 4127831 [No Abstract] [Full Text] [Related]
16. Correlation between thyrotropin-displacing activity and human thyroid-stimulating activity by immunoglobulins from patients with Graves' disease and other thyroid disorders. Sugenoya A; Kidd A; Row VV; Volpé R J Clin Endocrinol Metab; 1979 Mar; 48(3):398-402. PubMed ID: 218990 [TBL] [Abstract][Full Text] [Related]
17. Autoimmunity of thyroid disease. With emphasis on Graves' disease. van Ouwerkerk BM; Krenning EP; Docter R; Benner R; Hennemann G Neth J Med; 1985; 28(1):32-9. PubMed ID: 2858065 [No Abstract] [Full Text] [Related]
18. Suppressor T-lymphocyte deficiency in Graves' disease and Hashimoto's thyroiditis. Okita N; Row VV; Volpe R J Clin Endocrinol Metab; 1981 Mar; 52(3):528-33. PubMed ID: 6450775 [TBL] [Abstract][Full Text] [Related]
19. Activated (Ia+) T-lymphocytes and their subsets in autoimmune thyroid diseases: analysis by dual laser flow microfluorocytometry. Chan JY; Walfish PG J Clin Endocrinol Metab; 1986 Feb; 62(2):403-9. PubMed ID: 3484483 [TBL] [Abstract][Full Text] [Related]
20. Decrease of immunoglobulin G-Fc receptor-bearing T lymphocytes in Graves' disease. Mori H; Amino N; Iwatani Y; Asari S; Izumiguchi Y; Kumahara Y; Miyai K J Clin Endocrinol Metab; 1982 Sep; 55(3):399-402. PubMed ID: 6178751 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]